Yüklüyor......
Oral zinc sulphate for Wilson's disease.
After initial promotion of copper excretion with D-penicillamine, the effect of oral zinc sulphate (3 X 150 mg/day, loading dose; 3 X 100 mg/day, maintenance dose) in two children with clinically stable Wilson's disease was evaluated after completion of three years' treatment. The course,...
Kaydedildi:
Asıl Yazarlar: | , , , , |
---|---|
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
1985
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1777290/ https://ncbi.nlm.nih.gov/pubmed/4026362 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|